Mountcastle David sold $680K of PRVA
Mountcastle David (EVP & Chief Financial Officer) sold 24,734 shares of Privia Health Group, Inc. (PRVA) at $27.50 ($0.68M total) on 2026-07-02 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed sale size ($680,185) and post-transaction holdings (186,728 shares). This can marginally influence sentiment but does not introduce new company fundamentals.
Market read
Primarily a sentiment/positioning datapoint for PRVA; likely limited trading impact absent other catalysts.
What to watch
Traders may over-weight insider sales; without accompanying changes in guidance, contracts, or earnings, the disclosure is mostly informational rather than decision-driving.
Background
The article is an SEC Form 4 insider transaction: Mountcastle David (EVP & CFO) sold shares of Privia Health Group, Inc. under a 10b5-1 plan.
Ticker impact
Privia Health Group CFO David Mountcastle sold 24,734 shares in an open-market transaction under a 10b5-1 plan on July 2.
Low near-term impact; any reaction is likely limited to short-lived sentiment around insider selling.
The filing is a Form 4 insider transaction with a stated 10b5-1 pre-arranged plan, and it provides no new operating, guidance, or regulatory information.
Market effects
No direct sector read-through; this is company-specific insider trading disclosure.
None indicated.
None indicated.
Counterpoint
Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may be mechanically scheduled rather than a forward-looking negative signal.
Key entities
- issuerPrivia Health Group, Inc.
Subject of the Form 4 insider transaction; CFO David Mountcastle sold shares under a 10b5-1 plan.
- insiderDavid Mountcastle
EVP & CFO who executed the open-market sale disclosed in the Form 4.